Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice

Aim. To assess the efficacy and tolerance of certolizumab pegol (CP) in patients with Crohn's disease (CD) treated in the Department of inflammatory bowel diseases of the A.S. Loginov Moscow Clinical Research Center and to determine the predictors of response to therapy. Materials and methods....

Full description

Bibliographic Details
Main Authors: O V Knyazev, A V Kagramanova, A A Lishchinskaya, N G Samsonova, N V Orlova, V A Rogozina, A I Parfenov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2018-06-01
Series:Терапевтический архив
Subjects:
crohn’s disease
luminal form
perianal form
clinical remission
healing of mucosa
certolizumab pegol
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/32784/pdf

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/32784/pdf

Similar Items